Table 1 Patients’ characteristics at time of administration of IMM-101
Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
|---|---|---|---|---|
M1 stage AJCC v.8 | M1a (0) | M1c (1) | M1c (0) | M1b (0) |
Baseline LDH | Normal | Abnormal | Abnormal | Normal |
BRAF status | Wild-type | Wild-type | Wild-type | Wild-type |
Number of metastases | 6 | > 10 | > 10 | 5 |
Sites of metastases | Subcutaneous | Lung, peritoneum, stomach, nodes | Lung, subcutaneous, nodes, adrenal | Lung, subcutaneous |